Dietary zinc intake is associated with macular fluid in neovascular age-related macular degeneration

被引:10
|
作者
Dharamdasani Detaram, Harshil [1 ,2 ]
Mitchell, Paul [1 ,2 ]
Russell, Joanna [3 ]
Burlutsky, George [1 ,2 ]
Liew, Gerald [1 ,2 ]
Gopinath, Bamini [1 ,2 ]
机构
[1] Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Sydney, NSW, Australia
[2] Univ Sydney, Westmead Inst Med Res, Sydney, NSW, Australia
[3] Univ Wollongong, Sch Hlth & Soc, Fac Social Sci, Sydney, NSW, Australia
关键词
age-related macular degeneration; epidemiology; micronutrient; CLINICAL-TRIAL; VISUAL-ACUITY; ORAL ZINC; SUPPLEMENTATION; RANIBIZUMAB; THICKNESS;
D O I
10.1111/ceo.13644
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Importance Numerous dietary factors have been shown to reduce progression from early to late age-related macular degeneration (AMD), however, little is known on their impact in patients diagnosed with late-stage disease. Background To determine whether a dietary intake high in antioxidants and zinc, fruits, vegetables and fish is associated with favourable clinical outcomes in patients with neovascular AMD (nAMD) undergoing anti-vascular endothelial growth factor therapy. Design Cross-sectional study carried out at a private ophthalmology clinic. Participants Five hundred forty-seven participants with nAMD. Methods Diet was determined using a validated food frequency questionnaire. Presence of intra-retinal and sub-retinal fluid (IRF, SRF), pigment epithelial detachment and central macular thickness (CMT) were recorded from ocular coherence tomography images. Main Outcome Measures Fluid presence, mean CMT and visual acuity. Results Participants with daily zinc intake below (n = 91) vs above (n = 333) 8.1 mg had greater odds of SRF being present, multivariable-adjusted odds ratio (OR) of 0.56 (95% CI 0.36-0.96). This association was stronger in persons with at least 6 months of treatment, OR of 0.32 (95% CI 0.14-0.75). In the entire cohort, participants in the lowest or first quartile compared to those in the upper three quartiles of zinc intake combined had significantly greater mean CMT (254.81 mu m vs 232.15 mu m, respectively, multivariable-adjusted P = .03). Conclusions and Relevance Low dietary zinc intake was associated with a greater likelihood of SRF presence, particularly in those treated for at least 6 months, and increased macular thickness in treated eyes with nAMD.
引用
收藏
页码:61 / 68
页数:8
相关论文
共 50 条
  • [41] Guidance for the treatment of neovascular age-related macular degeneration
    Schmidt-Erfurth, Ursula M.
    Richard, Gisbert
    Augustin, Albert
    Aylward, William G.
    Bandello, Francesco
    Corcostegui, Borja
    Cunha-Vaz, Jose
    Gaudric, Alain
    Leys, Anita
    Schlingemann, Rainier O.
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 2007, 85 (05): : 486 - 494
  • [42] Review of Fibrosis in Neovascular Age-Related Macular Degeneration
    Cheong, Kai Xiong
    Cheung, Chui Ming Gemmy
    Teo, Kelvin Yi Chong
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2023, 246 : 192 - 222
  • [43] Intravitreal bevacizumab for neovascular age-related macular degeneration
    Ladewig, M. S.
    Ziemssen, F.
    Jaissle, G.
    Helb, H. -M.
    Scholl, H. P. N.
    Eter, N.
    Bartz-Schmidt, K. U.
    Holz, F. G.
    OPHTHALMOLOGE, 2006, 103 (06): : 463 - +
  • [44] Preferred therapies for neovascular age-related macular degeneration
    Lally, David R.
    Gerstenblith, Adam T.
    Regillo, Carl D.
    CURRENT OPINION IN OPHTHALMOLOGY, 2012, 23 (03) : 182 - 188
  • [45] Intravitreal bevacizumab for neovascular age-related macular degeneration
    Ladewig M.S.
    Ziemssen F.
    Jaissle G.
    Helb H.-M.
    Scholl H.P.N.
    Eter N.
    Bartz-Schmidt K.U.
    Holz F.G.
    Der Ophthalmologe, 2006, 103 (6): : 463 - 470
  • [46] Bevacizumab for the Treatment of Neovascular Age-Related Macular Degeneration
    Pitlick, Jamie M.
    Vecera, Kayla F.
    Barnes, Kylie N.
    Reski, John W.
    Forinash, Alicia B.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (02) : 290 - 296
  • [47] The nature and frequency of neovascular age-related macular degeneration
    Iranmanesh, R.
    Eandi, C. M.
    Peiretti, E.
    Klais, C. M.
    Garuti, S.
    Goldberg, D. E.
    Slakter, J. S.
    Yannuzzi, L. A.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2007, 17 (01) : 75 - 83
  • [48] Prospective study of zinc intake and the risk of age-related macular degeneration
    Cho, EY
    Stampfer, MJ
    Seddon, JM
    Hung, S
    Spiegelman, D
    Rimm, EB
    Willett, WC
    Hankinson, SE
    ANNALS OF EPIDEMIOLOGY, 2001, 11 (05) : 328 - 336
  • [49] Vitreomacular Adhesion and Neovascular Age-Related Macular Degeneration
    Simpson, Andrew R. H.
    Petrarca, Robert
    Jackson, Timothy L.
    SURVEY OF OPHTHALMOLOGY, 2012, 57 (06) : 498 - 509
  • [50] Innovative therapies for neovascular age-related macular degeneration
    Al-Khersan, Hasenin
    Hussain, Rehan M.
    Ciulla, Thomas A.
    Dugel, Pravin U.
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (15) : 1879 - 1891